HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
ID: 342928Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)." This grant aims to support action-oriented research that translates evidence-based practices into effective care systems for individuals facing addiction, with a focus on reducing overdose deaths through stigma-free, patient-centered approaches and outreach to underserved populations. The initiative is critical for enhancing the quality and accessibility of addiction care, emphasizing innovative strategies and stakeholder collaboration aligned with the HHS Overdose Prevention Strategy. Interested applicants can apply for funding up to $750,000, with a total anticipated funding of up to $15 million for related projects, and must submit their applications by March 20, 2025. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the full announcement at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-053.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has initiated funding opportunities under the HEAL Initiative to address the ongoing overdose crisis. The specific funding announcement, RFA-DA-23-053, seeks applications for action-oriented research aimed at translating evidence-based practices into tangible care systems for individuals experiencing addiction. The initiative addresses critical barriers to reducing overdose deaths, emphasizing stigma-free, patient-centered approaches and outreach to underserved populations. Funding aims to facilitate projects requiring preparatory work, such as stakeholder engagement and infrastructure development, progressing through an R61 phase (up to 2 years) followed by an R33 phase (up to 5 years). Up to $15 million is anticipated for both this and a related companion FOA. Applications must demonstrate innovative strategies, stakeholder collaboration, and alignment with the HHS Overdose Prevention Strategy pillars, focusing on harm reduction, recovery support, and treatment of substance use disorders. The initiative reflects a commitment to enhancing the quality and accessibility of addiction care, fostering research that prioritizes equitable health outcomes.
    Similar Opportunities
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative funding opportunity titled "Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-053). This initiative aims to support research that translates findings into actionable practices to combat the ongoing overdose crisis in the U.S., with a focus on developing innovative, scalable, and equitable strategies for patient-centered care in addiction treatment. The funding mechanism allows for projects to span up to six years, divided into a two-year planning phase (R61) and a five-year implementation phase (R33), with an anticipated total funding of up to $15 million based on the quality of applications received. Interested applicants can find more details and submission guidelines at the provided link and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. The application deadline is March 20, 2025.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of preventive services for substance use disorders, specifically focusing on opioid misuse. This initiative invites applications for research that addresses gaps in the dissemination and implementation of prevention services, with a phased R61/R33 award mechanism allowing for up to six years of support, contingent on the successful completion of preliminary milestones. The overarching goal is to establish a sustainable prevention infrastructure that effectively reduces risks associated with substance use, emphasizing equity and community involvement in the research process. Interested applicants can find more information and apply by the deadline of January 16, 2026, with a projected funding amount of $4.65 million for the 2024 fiscal year. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-066.html.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity under the HEAL Initiative, aimed at enhancing the implementation and sustainability of substance use preventive services. This initiative seeks to address the critical gaps between effective prevention research and its practical application, particularly in combating the opioid crisis, by soliciting applications for projects that demonstrate preliminary data and focus on strengthening prevention infrastructure. With approximately $4.65 million available for funding, grants can support projects for up to five years, with annual budget requests advised to remain under $800,000. Interested applicants must submit their proposals by January 16, 2026, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a grant opportunity titled the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23), aimed at supporting early career researchers and clinicians in the field of addiction. Applicants are required to have clinical training and must propose an independent clinical trial that aligns with the HHS Overdose Prevention Strategy, focusing on areas such as opioid misuse prevention, treatment, harm reduction, and recovery support services. This initiative is crucial for addressing the ongoing substance use crisis by fostering a new generation of implementation researchers who can effectively translate research into clinical practice. Interested applicants can find more information and apply by November 12, 2025, with funding support of up to $100,000 per year for salary and additional research costs. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAS-22-207.html.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01), aimed at supporting early career researchers in developing expertise in implementation science related to substance use treatment and prevention. Applicants are required to conduct an independent clinical trial that applies implementation science to one of the four priority domains of the HHS Overdose Prevention Strategy, which includes prevention, treatment, harm reduction, and recovery support services. This initiative is crucial in addressing the ongoing overdose crisis by promoting the integration of evidence-based practices into routine care, fostering a diverse research community, and ensuring equitable access to effective treatment resources. The funding amount is approximately $1.1 million for FY2023, with awards anticipated for 3-5 years of research, and applications are due by November 12, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Clinical Research Hubs, which requires a UM1 clinical trial. This initiative aims to address the opioid overdose crisis by researching effective interventions for individuals with substance use disorders (SUD) within the criminal justice system, focusing on optimizing treatment and enhancing collaboration between justice and community health agencies. The program anticipates funding 8-10 awards, with a total budget of approximately $14 million over five years, and emphasizes the importance of stakeholder engagement and diverse perspectives in the research process. Interested applicants must submit their proposals by January 22, 2025, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.